Dr. Hagar Labouta joins the College of Pharmacy with more than 15 years of research experience in drug delivery, pharmaceutical nanotechnology, nanotoxicology, and biomedical engineering. At the early stage of her research career, she became convinced that using nanostructures for drug delivery and diagnosis would revolutionize the pharmaceutical and biomedical fields. She completed her Ph.D. in pharmaceutical nanotechnology at Saarland University (Germany). Under the supervision of Prof. Marc Schneider, she focused on understanding the interaction of gold nanoparticles with skin layers using multiphoton microscopy. Upon completion of her Ph.D. studies, Dr. Labouta graduated with the highest honour, a summa cum laude. Her outstanding research achievements were also acknowledged with a prestigious award “Apotheker Jacob Prize” in 2012.
Dr. Labouta completed postdoctoral trainings in Pharmaceutical Sciences and Nanoscience at several international institutes. She obtained her first postdoctoral position at the biggest hub of Pharmaceutical Sciences in Germany, comprising several academic and industrial institutes. Within this hub, she joined the Drug Delivery Department, Helmholtz institute for Pharmaceutical Research (Germany) under the supervision of Prof. Claus-Michael Lehr where she focused on the development of cellular bioinvasive nanoparticles for drug delivery and infection control, as well as designing nanoparticle-based inhalations for the treatment of cystic fibrosis.
Dr. Labouta’s dedication to excel in new research areas brought her to the University of Calgary (Canada), where she focused on other nanomedicinal research areas at the Department of Chemistry under the supervision of Prof. David Cramb and the Department of Biomedical Engineering under the supervision of Prof. Kristina Rinker. The main focus of her research was tumour targeting and designing new platforms and frameworks for the in vitro assessment of cellular toxicity of nanoparticles.
Her appreciation of the interdisciplinary scientist identity she developed over the years urged her to investigate the ways that interdisciplinary learning environments foster interdisciplinary research habits in students (future scientists and pharmacists). She became the first postdoctoral appointee in STEM education research in the history of Faculty of Science, University of Calgary. She received a grant through the Taylor Institute for Teaching and Learning to study interdisciplinary science learning. She also received a curriculum award for her transparent assessment methods at the Nanoscience Program at University of Calgary for her transparent assessment methods based on her research.
Overall, Dr. Labouta has deep and comprehensive knowledge and expertise in the formulation and characterisation of a wide range of novel nano drug delivery systems for biomedical and pharmaceutical applications: polymeric and metallic nanoparticles, liposomes, as well as nanofibres prepared by electrospinning. In addition to the formulation skills in nano- and micro-systems, she is an expert in confocal and multiphoton microscopy techniques, as well as fluorescence spectroscopy. Moreover, Dr. Labouta is familiar with cell culture techniques. She has a long working experience with different skin models (human and tissue-cultured skin tissue). Her other research interests include experimental design using multivariant factorial analysis and modeling artificial intelligence. Dr. Labouta has a strong publication record and is a co-inventor on an international patent for the development of carrier systems for intracellular drug targeting. She has won several awards and fellowships including 2015 Innovation and Career Development Award by the Biomedical Engineering Society. Throughout her career, she has collaborated with several multi-disciplinary teams at 15 research institutes in Canada, Germany, Australia, USA, Egypt and Finland. She has also worked with the World Health Organization on two health-related projects.
As a pharmacist and nanoscientist, Dr. Labouta’s goal is to combine her knowledge and expertise in these fields to design and conduct research projects that would have high impact on healthcare and pharmaceutical industry.
Nanotechnology, or more appropriately nanoscience, is a multidisciplinary branch of science that currently receives a lot of attention from researchers in the pharmaceutical and biomedical fields. Using nanoparticles in drug delivery and diagnostics offers several advantages over traditional formulations, such as modified pharmacokinetics and tissue distribution, site-specific targeting, reduced toxicity, prolonged release, improved stability and bioavailability.
Nanoparticles continue to be touted for their excellent theranostic potential however a globalized cause and effect model relating nanoparticle properties to their behaviour in biological systems has not been developed. The main overarching focus of this research program is in-depth understanding of the interaction of nanocomposites formed in vivo on administration of the native nanoparticles within the different biological compartments and translating this knowledge to arrive to predictive models for designing nanomaterials with optimal physicochemical attributes.
The knowledge generated from this research program could be employed directly for the development of novel drug delivery systems and diagnostic agents. It will potentially impact the entire nanomedicinal field by offering a solid basis for innovative design solutions. Furthermore, it is expected that this knowledge will influence national and international policies on the regulation of nanoparticles.
Applications of nanotechnology in pharmaceutical and biomedicinal fields including:
2018-2019 Nanoscience research associate, Department of Chemistry, Faculty of Science, University of Calgary, Canada
2016-2018 Teaching Postdoctoral Scholar, Nanoscience Program, Faculty of Science, University of Calgary, Canada
2014-2016 Eyes-High Postdoctoral Fellow, Department of Chemistry, Faculty of Science Biomedical Engineering Program, CMBR Lab (Cellular and Molecular Bioengineering Research Lab), University of Calgary, Canada
2012-2014 Postdoctoral Associate, Department of Drug Delivery (DDEL), Helmholtz Institute for Pharmaceutical Research-Saarland (HIPS), Germany
2009-2011 Ph.D. of natural sciences, Institute of Biopharmaceutics and Pharmaceutical Technology, Dept. of Pharmaceutical Nanotechnology, Saarland University, Germany
2004-2007 MSc. of Pharmaceutical Sciences, Department of Pharmaceutics, Alexandria University, Egypt
1998-2003 BSc. in pharmaceutical sciences, Faculty of pharmacy, Alexandria University, Egypt
For contact details, visit
the faculty directory.